Guest: Professor Marco Falasca
Presenter: Henry Acosta
Guest Bio: Prof Falasca graduated in Pharmacy and then in Pharmaceutical Chemistry at the University of Camerino, Italy. His education further includes a “Diploma of Specialization” in Applied Pharmacology at the University of Bari and a FORMEZ Research Award (PhD equivalent) at the Consorzio Mario Negri Sud, Italy. After three years at the New York University Medical Center, Department of Pharmacology (Head Prof Joseph Schlessinger), Prof Falasca took up a position as Head of the Unit of Physiopathology of Cell Signalling within the Consorzio Mario Negri Sud in 1998. In 2001 he moved to London where he was appointed as Principal Research Fellow, Senior Lecturer within the Department of Medicine at the University College London. In 2007 he was appointed as Professor of Molecular Pharmacology at the Queen Mary University of London. He is currently Professor of Metabolism at Curtin University, Australia. He has published more than 100 papers in reputed journals and has been serving as an editorial board member for several international journals.
Segment overview: In today’s segment, we are joined by Professor Marco Falasca from Curtin University here to talk about what is medicinal cannabis and what the university is investigating in this area. This week, the first commercial shipments of medicinal cannabis products have arrived in Perth from Canada. Professor Falasca will be also be discussing, as a specialist in metabolic science, their research into medicinal cannabis treatment at the Curtin Health Innovation Research Institute.
Health Professional Radio – Medicinal Cannabis